cGAS-STING Signaling Pathway and Liver Disease: From Basic Research to Clinical Practice

被引:40
作者
Chen, Bangjie [1 ]
Rao, Xianyue [1 ]
Wang, Xinyi [2 ]
Luo, Zhipan [1 ]
Wang, Jianpeng [2 ]
Sheng, Shuyan [2 ]
Liu, Yuchen [1 ]
Zhang, Ning [2 ]
Jin, Shiyu [2 ]
Chen, Haosong [2 ]
Sun, Chenyu [3 ]
Xu, Tao [4 ,5 ]
Du, Yingying [1 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China
[2] Anhui Med Univ, Clin Med Coll 1, Hefei, Peoples R China
[3] AMITA Hlth St Joseph Hosp, Chicago, IL USA
[4] Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei, Peoples R China
[5] Anhui Med Univ, Sch Pharm, Hefei, Peoples R China
关键词
CGAS; STING; liver; inflammation; cancer; NF-KAPPA-B; VIRUS REPLICATION; INNATE IMMUNITY; DNA SENSOR; INFLAMMATION; CANCER; CELLS; ACTIVATION; INJURY; CONTRIBUTES;
D O I
10.3389/fphar.2021.719644
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The cGAS-STING signaling pathway is an autoimmune inflammatory pathway that can trigger the expression of a series of inflammatory factors represented by type 1 interferon. Recent studies have found that the cGAS-STING signaling pathway played a significant role in liver physiology and was closely related to the progress of liver diseases. For example, activating the cGAS-STING signaling pathway could significantly inhibit hepatitis B virus (HBV) replication in vivo. Moreover, the cGAS-STING signaling pathway was also closely associated with tumor immunity in hepatocellular carcinoma (HCC). This review summarized the role of the cGAS-STING signaling pathway in several common liver diseases, especially the current application of the cGAS-STING signaling pathway in liver disease treatment, and prospected its future research, which provided a new idea for understanding and treating liver diseases.
引用
收藏
页数:11
相关论文
共 88 条
[1]
Cytosolic-DNA-Mediated, STING-Dependent Proinflammatory Gene Induction Necessitates Canonical NF-κB Activation through TBK1 [J].
Abe, Takayuki ;
Barber, Glen N. .
JOURNAL OF VIROLOGY, 2014, 88 (10) :5328-5341
[2]
Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP [J].
Ablasser, Andrea ;
Schmid-Burgk, Jonathan L. ;
Hemmerling, Inga ;
Horvath, Gabor L. ;
Schmidt, Tobias ;
Latz, Eicke ;
Hornung, Veit .
NATURE, 2013, 503 (7477) :530-+
[3]
Microbiota, cirrhosis, and the emerging oral-gut-liver axis [J].
Acharya, Chathur ;
Sahingur, Sinem Esra ;
Bajaj, Jasmohan S. .
JCI INSIGHT, 2017, 2 (19)
[4]
Liver-Microbiome Axis in Health and Disease [J].
Adolph, Timon E. ;
Grander, Christoph ;
Moschen, Alexander R. ;
Tilg, Herbert .
TRENDS IN IMMUNOLOGY, 2018, 39 (09) :712-723
[5]
Management Strategies for Liver Fibrosis [J].
Altamirano-Barrera, Alejandra ;
Barranco-Fragoso, Beatriz ;
Mendez-Sanchez, Nahum .
ANNALS OF HEPATOLOGY, 2017, 16 (01) :48-56
[6]
Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment [J].
Ashfaq, Usman Ali ;
Riaz, Muhammad ;
Yasmeen, Erum ;
Yousaf, Muhammad Zubair .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2017, 34 (04) :317-353
[7]
Burden of liver diseases in the world [J].
Asrani, Sumeet K. ;
Devarbhavi, Harshad ;
Eaton, John ;
Kamath, Patrick S. .
JOURNAL OF HEPATOLOGY, 2019, 70 (01) :151-171
[8]
The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment [J].
Bakhoum, Samuel F. ;
Cantley, Lewis C. .
CELL, 2018, 174 (06) :1347-1360
[9]
STING: infection, inflammation and cancer [J].
Barber, Glen N. .
NATURE REVIEWS IMMUNOLOGY, 2015, 15 (12) :760-770
[10]
Behrends Christian, 2012, Int J Cell Biol, V2012, P673290, DOI 10.1155/2012/673290